Literature DB >> 3902971

A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material.

J V Watson, K Sikora, G I Evan.   

Abstract

A simultaneous flow cytometric assay for the c-myc oncoprotein and DNA in nuclei extracted from archival paraffin wax embedded clinical biopsies is presented. The nuclei were extracted by pepsin digestion after dewaxing 20 micron sections. The c-myc oncoprotein was probed with a mouse monoclonal antibody. This was raised against a synthetic peptide corresponding to a hydrophilic region of the protein predicted from the amino acid sequence. The technique is illustrated with biopsies from patients with testicular cancer and with benign and malignant neoplasms of the colon.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902971     DOI: 10.1016/0022-1759(85)90071-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  19 in total

1.  Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.

Authors:  S Rowley; K M Newbold; J Gearty; M R Keighley; I A Donovan; J P Neoptolemos
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

2.  Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.

Authors:  V Sundaresan; I C Forgacs; D G Wight; B Wilson; G I Evan; J V Watson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

3.  c-myc oncoprotein levels in bladder cancer.

Authors:  J R Masters; S G Vesey; C F Munn; G I Evan; J V Watson
Journal:  Urol Res       Date:  1988

4.  Cervical brush biopsy specimens suitable for DNA and oncoprotein analysis using flow cytometry.

Authors:  J Elias-Jones; P Hendy-Ibbs; H Cox; G I Evan; J V Watson
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

Review 5.  Oncogenes and gastrointestinal cancer.

Authors:  I Forgacs
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

6.  c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.

Authors:  J S Chana; G D Wilson; I A Cree; R A Alexander; N Myatt; M Neale; A J Foss; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

7.  Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumours.

Authors:  P A van Dam; J V Watson; D G Lowe; H Cox; M Curling; J H Shepherd
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

8.  Papillomavirus and c-myc antigen expression in normal and neoplastic cervical epithelium.

Authors:  R G Hughes; W A Neill; M Norval
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

9.  Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.

Authors:  M Curling; S Stenning; C N Hudson; J V Watson
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

10.  Phenotypic characteristics of three human non-Hodgkin lymphoma lines: flow cytometric analysis after long-term maintenance.

Authors:  L Kopper; A Bánkfalvi; R Mihalik; K Páloczi; M Benczur; K Lapis
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.